News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
16,252 Results
Type
Article (2755)
Company Profile (3)
Press Release (13494)
Multimedia
Podcasts (9)
Webinars (1)
Section
Business (6290)
Career Advice (86)
Deals (969)
Drug Delivery (8)
Drug Development (2613)
Employer Resources (6)
FDA (460)
Job Trends (730)
News (10229)
Policy (1074)
Tag
Academia (41)
Allergies (4)
Alliances (1506)
ALS (6)
Alzheimer's disease (17)
Antibody-drug conjugate (ADC) (8)
Approvals (464)
Artificial intelligence (12)
Autoimmune disease (7)
Bankruptcy (8)
Best Places to Work (489)
Biosimilars (4)
Biotechnology (1)
Breast cancer (3)
Cancer (54)
Cardiovascular disease (7)
Career advice (64)
CAR-T (2)
Cell therapy (8)
Clinical research (2135)
Collaboration (27)
Compensation (4)
Complete response letters (3)
COVID-19 (204)
CRISPR (2)
C-suite (18)
Cystic fibrosis (2)
Data (63)
Diabetes (16)
Diagnostics (66)
Diversity, equity & inclusion (1)
Drug discovery (7)
Drug pricing (13)
Duchenne muscular dystrophy (1)
Earnings (1505)
Editorial (5)
Employer branding (2)
Employer resources (5)
Events (1279)
Executive appointments (46)
FDA (504)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (32)
Gene editing (4)
Generative AI (1)
Gene therapy (9)
GLP-1 (74)
Government (219)
Grass and pollen (1)
Guidances (6)
Healthcare (302)
Huntington's disease (1)
Immunology and inflammation (25)
Indications (4)
Infectious disease (216)
Inflammatory bowel disease (9)
Inflation Reduction Act (1)
Influenza (3)
Intellectual property (2)
Interviews (14)
IPO (217)
IRA (3)
Job creations (266)
Job search strategy (64)
Labor market (1)
Layoffs (41)
Legal (258)
Liver cancer (2)
Lung cancer (7)
Lymphoma (5)
Machine learning (1)
Management (2)
Manufacturing (10)
Medical device (56)
Medtech (56)
Mergers & acquisitions (755)
Metabolic disorders (29)
Multiple sclerosis (14)
Neurodegenerative disease (8)
Neuropsychiatric disorders (1)
Neuroscience (46)
NextGen: Class of 2025 (166)
Non-profit (66)
Obesity (10)
Opinion (36)
Ovarian cancer (2)
Pain (2)
Pancreatic cancer (2)
Patents (3)
Patient recruitment (3)
Peanut (1)
People (2929)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase I (568)
Phase II (839)
Phase III (979)
Pipeline (54)
Policy (6)
Postmarket research (172)
Preclinical (165)
Psychedelics (1)
Radiopharmaceuticals (11)
Rare diseases (24)
Real estate (181)
Recruiting (3)
Regulatory (722)
Reports (2)
Research institute (44)
Resumes & cover letters (14)
RNA editing (1)
RSV (5)
Series A (5)
Series B (8)
Sickle cell disease (1)
Special edition (3)
Spinal muscular atrophy (19)
Startups (152)
Supply chain (2)
Tariffs (4)
The Weekly (9)
Vaccines (62)
Venture capitalists (3)
Weight loss (10)
Date
Last 7 days (22)
Last 30 days (88)
Last 365 days (790)
2025 (322)
2024 (781)
2023 (791)
2022 (1633)
2021 (1482)
2020 (1214)
2019 (842)
2018 (708)
2017 (921)
2016 (816)
2015 (1071)
2014 (724)
2013 (603)
2012 (625)
2011 (646)
2010 (651)
Location
Africa (61)
Asia (844)
Australia (109)
California (187)
Canada (18)
China (39)
Colorado (1)
Connecticut (2)
Delaware (1)
Europe (4423)
Florida (7)
Illinois (3)
India (1)
Indiana (3)
Japan (4)
Kansas (1)
Maryland (14)
Massachusetts (72)
Michigan (1)
Minnesota (2)
Nebraska (1)
New Hampshire (1)
New Jersey (20)
New York (81)
North Carolina (7)
Northern California (144)
Pennsylvania (17)
South America (66)
Southern California (34)
Texas (8)
United States (427)
Utah (5)
Virginia (3)
Washington D.C. (1)
Washington State (4)
Wisconsin (1)
16,252 Results for "sanofi genzyme".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Clinical research
Sanofi’s $1.4B Kymab Bet Falters as Asthma Drug Stumbles in Phase II
Analysts at Leerink agreed with Sanofi that, despite falling short of statistical significance in the Phase II TIDE-Asthma trial, amlitelimab warrants further development in this indication.
April 16, 2025
·
2 min read
·
Tristan Manalac
FDA
FDA Action Alert: Regeneron, Sanofi and Abeona
Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for Regeneron, one with partner Sanofi.
April 14, 2025
·
3 min read
·
Tristan Manalac
Earnings
Sanofi Earnings Driven by Dupixent, New RSV Vaccine as Hunt for Deals Continues
Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.
January 30, 2025
·
2 min read
·
Dan Samorodnitsky
I&I
Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease
The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can achieve deep B cell depletion, giving it the potential to reset the immune system.
March 20, 2025
·
2 min read
·
Tristan Manalac
Legal
Regeneron Sues Sanofi, Alleging Stonewalling in Dupixent Pact
According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent—including agreements with payers and pharmacy benefit managers that determine pricing and rebates for the drug.
February 7, 2025
·
2 min read
·
Tristan Manalac
Legal
Sanofi Sues Sarepta Over Elevidys DMD Gene Therapy, Alleges Patent Infringement
Sarepta has been hit with another patent infringement lawsuit, this time from Sanofi and its subsidiary Genzyme alleging that the biotech used protected technology related to AAV vectors.
August 1, 2024
·
2 min read
·
Tristan Manalac
Vaccines
Sanofi Hit With $250M Impairment After Scrapping J&J-Partnered
E. coli
Vaccine
Without providing specific data, Sanofi on Thursday announced that the experimental vaccine did not significantly prevent invasive
E. coli
disease versus placebo.
February 13, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA Action Alert: GSK, Sanofi, Merck and More
On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s oral cancer drug for a pair of rare tumors.
May 5, 2025
·
6 min read
·
Tristan Manalac
Press Releases
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
April 15, 2025
·
10 min read
Press Releases
Innate Pharma Regains Its Rights on CD123 Targeting ANKET® and Announces Sanofi’s Intention to Make a Strategic Investment in the Company
April 23, 2025
·
7 min read
1 of 1,626
Next
